Thalassemia

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

Recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Nashville, Tennessee
  • +5 more
Feb 2, 2023

Thalassemia Trial in Canada, United Kingdom, United States (AG-348)

Active, not recruiting
  • Thalassemia
  • Oakland, California
  • +3 more
Jan 26, 2023

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

Active, not recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Stanford, California
  • +11 more
Nov 30, 2022

A Long-term Follow-up Study in Subjects Who Received CTX001

Enrolling by invitation
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • New York, New York
  • +12 more
Nov 18, 2022

Multi-Center Study of Iron Overload: Pilot Study

Completed
  • Sickle Cell Disease
  • +2 more
    • Oakland, California
    • +2 more
    Sep 22, 2020

    Multi-Center Study of Iron Overload: Survey Study (MCSIO)

    Completed
    • Sickle Cell Disease
    • +2 more
      • Oakland, California
      • +7 more
      Sep 22, 2020

      Hepatitis C, Thalassemia Trial in Canada, United Kingdom, United States (Peginterferon Alfa-2a and Ribavirin, Ribavirin)

      Completed
      • Hepatitis C
      • Thalassemia
      • Oakland, California
      • +4 more
      Mar 3, 2014

      People With Thalassemia: The Thalassemia Longitudinal Cohort

      Completed
      • Thalassemia
        • Los Angeles, California
        • +13 more
        Nov 9, 2011

        Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia Trial in Worldwide (Deferasirox)

        Completed
        • Thalassemia
        • +3 more
        • Little Rock, Arkansas
        • +140 more
        Jun 3, 2011